“Dupilumab-Treated Patients With Prurigo Nodularis Report Disease Control and Treatment Satisfaction: 6-Month Results From the RELIEVE-PN Study”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s716, https://doi.org/10.25251/h522p595.